Are there any contraindications or precautions dermatologists should consider before beginning a patient on ruxolitinib for vitiligo?

Featuring Benjamin Lockshin, MD | EVP of Strategic Initiatives Director of the Clinical Trials Center Assistant Professor US Dermatology Partners Georgetown University Rockville, MD | Published July 01, 2024